Johnson & Johnson JNJ NYSE

Johnson & Johnson (JNJ) reported total assets of $199.21B and total liabilities of $117.67B for quarter ending 2025-12-28, resulting in total equity of $81.54B.

The company held $20.1B in cash and short-term investments. Total debt stood at $47.93B, with net debt of $28.22B. The Debt-to-Equity (D/E) ratio was 0.59 (moderate).

Current ratio is 1.03, suggesting adequate short-term liquidity. Interest coverage is 12.2x (strong).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (100/100) — Total assets $199.21B and equity $81.54B support the company's competitive scale
• VALUE (38/100) — Debt-to-Equity 0.59 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 73/100 with 4/7 criteria passed.